Liu et al. conducted a clinical study including 535 patients diagnosticated with colorectal cancer to compare the expression of immune-related genes and the abundance of tumor-infiltrating immune cells in the tumor microenvironment between KRAS-mutant and KRAS wild-type patients. The gene discussed is KRAS; the disease is neoplasm.